Women and COPD: do we need more evidence?

Area of Science:

• Pulmonology
• Epidemiology
• Women's Health

Background:

• Chronic obstructive pulmonary disease (COPD) prevalence in women has equaled men since 2008.
• Increased tobacco use and biomass fuel exposure contribute to rising COPD rates in women globally.
• Women exhibit unique susceptibility to airborne contaminants, influencing disease presentation.

Purpose of the Study:

• To examine the epidemiological shifts in COPD affecting women.
• To understand the distinct clinical manifestations and impacts on quality of life in women with COPD.
• To identify barriers to diagnosis and treatment for women with COPD.

Main Methods:

• Review of epidemiological data on COPD prevalence in women.
• Analysis of clinical characteristics, phenotypic manifestations, and quality of life impacts.
• Assessment of factors contributing to susceptibility and treatment disparities.

Main Results:

• COPD is the leading cause of death for women in the USA.
• Women with COPD present with increased dyspnea, anxiety, depression, undernutrition, non-small cell lung cancer, and osteoporosis.
• Quality of life is significantly more impacted in women compared to men.
• Barriers include under-diagnosis, fewer spirometry tests, and reduced medical consultations for women.

Conclusions:

• The changing epidemiology of COPD necessitates updated knowledge and adapted therapeutic strategies for women.
• Biological (e.g., estrogen) and behavioral (e.g., smoking) factors may explain differences in COPD presentation and impact.
• Addressing diagnostic and treatment barriers is crucial for improving outcomes in women with COPD.